Reagents; (closely associated functions)
Ended Awarded Last action
- Contract number
- 0005
- Awardee
-
Diasorin Inc. UEI FGK2QR959BV5 Part of Diasorin S.P.A.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $350,000
Award facts
- Contract value 100% obligated
- $350,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 621511 Medical Laboratories
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20889, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $350,000 | |
| Original award | $0 |
About this award
This federal contract award for $350,000 was issued by the Defense Health Agency (DHA) to Diasorin Inc., a foreign-owned, for-profit medical diagnostics company. The contract is for the provision of reagents and closely associated functions, with an ultimate completion date of September 30, 2017. This award is a Blanket Purchase Agreement (BPA) call, with a firm fixed price pricing type.
Diasorin Inc. is a subsidiary of the Italian-based Diasorin S.P.A. and has a significant presence in the U.S. federal healthcare market, specializing in chemiluminescence immunoassay technologies. The company's core product line includes the LIAISON XL and LIAISON XS analyzers, which are used for detecting and testing various infectious diseases, including COVID-19, tuberculosis, varicella, and cytomegalovirus.
This contract award did not utilize any set-aside designations, reflecting Diasorin's competitive positioning and specialized technological capabilities in medical diagnostics. Diasorin Inc. holds several significant federal contract Indefinite Delivery Vehicles (IDVs), including a $2.8 million General Services Administration (GSA) Multiple Award Schedule contract and multiple VA-specific Indefinite Delivery Contracts (IDCs), which enable federal agencies to efficiently procure the company's diagnostic solutions.
Quick answers
Who was awarded contract 0005?
0005 was awarded to Diasorin Inc. by Defense Health Agency (Department of Defense) on September 30, 2016.
How much is contract 0005 worth?
The government has obligated $350,000 on 0005.
Is contract 0005 an order under another contract?
Yes. 0005 is a BPA call under HT001414A0012, a blanket purchase agreement.
Was contract 0005 competed?
The extent of competition for 0005 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award